查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
拉丁美洲化學發光免疫分析市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍：按應用、最終用戶和國家分類
市場調查報告書
商品編碼
1571390

拉丁美洲化學發光免疫分析市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍：按應用、最終用戶和國家分類

Latin America Chemiluminescence Immunoassay Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Country
出版日期: | 出版商: The Insight Partners | 英文 88 Pages | 訂單完成後即時交付

價格

拉丁美洲化學發光免疫分析市場規模預計將從2023年的4.9767億美元成長到2031年的9.5512億美元；預計 2023-2031 年複合年成長率為 8.6%。

腿部加壓包紮旨在控制和緩解淋巴水腫症狀。這些包裹物透過對腿部受影響的區域施加控制壓力來幫助淋巴流動並減少腫脹。與傳統的壓力襪相比，壓力襪是可調節的，使其成為難以穿著壓力襪或水腫程度波動的個人的理想選擇。可調式壓縮包布的成本要低得多，並且在實現潰瘍癒合方面更有效。因此，在治療腿部靜脈潰瘍時，可調節加壓包紮是非彈性繃帶的強大、自用且經濟有效的替代方案。靜脈疾病發生率的增加和導致淋巴水腫的癌症發生率的增加是導致拉丁美洲化學發光免疫分析市場擴大的重要因素。然而，替代療法的可用性阻礙了拉丁美洲化學發光免疫分析市場的成長，因為淋巴水腫、慢性靜脈功能不全、周邊水腫、靜脈瘀血性潰瘍和靜脈曲張等疾病也可以透過藥物和外科手術（尤其是微創手術）進行治療。其他用於治療上述病症的治療程序包括泡沫硬化療法、雷射治療、門診靜脈切除術以及使用射頻或雷射能量的導管輔助程序。間歇性氣動加壓裝置等技術也可用於防止腿部深層靜脈血栓。它採用一種裝置來模仿自然肌肉收縮，幫助靜脈回流。因此，替代療法的可用性，例如用於治療上述病症的壓縮衣、設備和療法，阻礙了拉丁美洲化學發光免疫分析市場的成長。

基於應用程式的見解

根據應用，拉丁美洲化學發光免疫分析市場分為腫瘤學、生育力、內分泌學、心臟病學、傳染病、糖尿病等。 2023 年，腫瘤學領域佔據了拉丁美洲化學發光免疫分析市場最大佔有率。 根據《刺胳針》報道，截至2023 年，拉丁美洲和加勒比海(LAC) 地區每年記錄約150 萬新癌症病例和約70 萬癌症相關死亡。 ，每10 萬人中95 人。據巴西癌症雜誌Revista Brasileira de Cancerologia 稱，2023 年巴西報告了近704,000 例新癌症病例。 A (CgA) 水平。此檢測可作為輔助檢測嗜鉻細胞瘤和神經內分泌腫瘤（如類癌等）患者。

此外，預計2023 年至2031 年生育領域的複合年成長率最高。以及12,778 例分娩和分娩。根據拉丁美洲和加勒比海經濟委員會的數據，拉丁美洲的總生育率（TFR）在 2015 年低於更替水平，預計 2022 年每名婦女的活產數為 1.85，進一步預測將降至 1.68到2100 年。平均生育年齡也有增加。 Biopanda催乳素化學發光免疫分析檢測試劑盒提供了一種定量測定人類血清中催乳素的方法。化學發光免疫分析法由於相關性高、實用性增強等因素，已取代放射免疫分析法成為目前血清孕酮測定的標準。因此，上述因素支持了拉丁美洲化學發光免疫分析市場的成長。

基於最終用戶的見解

根據最終用戶，拉丁美洲化學發光免疫分析市場分為醫院、血庫、臨床實驗室、製藥和生物技術公司等。 2023 年，醫院細分市場佔據拉丁美洲化學發光免疫分析市場最大佔有率，預計臨床實驗室細分市場在 2023-2031 年期間將實現最高的複合年成長率。免疫診斷測試在醫院的不同部門進行，包括臨床微生物實驗室、病理實驗室、血清學實驗室、組織病理學和血液學科室、臨床生化實驗室和醫院病房。一些免疫診斷儀器可以快速提供結果，而在進行複雜測試時，樣本會被送到專門的實驗室。醫院環境中對即時 (POC) 免疫分析測試產品的需求不斷成長，有利於 CLIA 市場。目前，CLIA檢測主要用於檢測腫瘤標記以及診斷傳染病、內分泌失調、糖尿病等。透過在一個自動化系統中實現如此多樣化的應用，CLIA 系統在醫院中具有重要的適用性。

然而，按照國內或國際監管要求建立的診斷實驗室使用基於 CLIA 的試劑盒和儀器為醫院、診所、家庭護理機構等提供診斷服務。的實踐是支持拉丁美洲化學發光免疫分析診斷實驗室市場成長的因素。

全球癌症觀測站、經合組織和國家生物技術資訊中心是準備拉丁美洲化學發光免疫分析市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 3 章：拉丁美洲化學發光免疫分析 (CLIA) 市場格局

  • 市場概況
  • PEST分析

第 4 章：拉丁美洲化學發光免疫分析 (CLIA) 市場 - 主要市場動態

  • 拉丁美洲化學發光免疫分析市場 - 主要市場動態
  • 市場促進因素：
    • 傳染病發生率上升
    • 擴大使用現場診斷
  • 市場限制
    • 報銷不足
  • 市場機會
    • 更加重視研發
  • 未來趨勢
    • 技術進步
  • 促進因素和限制的影響：

第 5 章：拉丁美洲化學發光免疫分析 (CLIA) 市場分析

  • 化學發光免疫分析（CLIA）市場
    • 概述
    • 化學發光免疫分析 (CLIA)：化學發光免疫分析 (CLIA) 市場 - 收入和 2031 年預測

第 6 章：拉丁美洲化學發光免疫分析 (CLIA) 市場分析 - 按應用

  • 腫瘤學
  • 生育能力
  • 內分泌科
  • 心臟病學
  • 傳染病
  • 糖尿病
  • 其他

第 7 章：拉丁美洲化學發光免疫分析 (CLIA) 市場分析 - 按最終用戶

  • 醫院
  • 血庫
  • 臨床實驗室
  • 製藥和生物技術公司
  • 其他

第 8 章：拉丁美洲化學發光免疫分析 (CLIA) 市場 - 區域分析

  • 概述
  • 拉丁美洲
    • 拉丁美洲化學發光免疫分析 (CLIA) 市場概況
    • 拉丁美洲：拉丁美洲化學發光免疫分析 (CLIA) - 收入和 2031 年預測
      • 拉丁美洲：拉丁美洲化學發光免疫分析 (CLIA) 市場 - 收入和預測分析 - 按應用
      • 拉丁美洲：拉丁美洲化學發光免疫分析 (CLIA) 市場 - 收入和預測分析 - 按最終用戶
      • 巴西：化學發光免疫分析 (CLIA) 市場 - 收入和 2031 年預測
      • 阿根廷：化學發光免疫分析 (CLIA) 市場 - 收入和 2031 年預測
      • 智利：化學發光免疫分析 (CLIA) 市場 - 收入和 2031 年預測
      • 墨西哥：化學發光免疫分析 (CLIA) 市場 - 收入和 2031 年預測
      • 拉丁美洲其他地區：化學發光免疫分析 (CLIA) 市場 - 收入和 2031 年預測

第 9 章：公司簡介

  • Sysmex Corp
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd
  • DiaSorin SpA
  • Siemens Healthineers AG
  • Getein Biotech Inc.

第 10 章：附錄

Product Code: TIPRE00039333

The Latin America chemiluminescence immunoassay market size is expected to grow from US$ 497.67 million in 2023 and is projected to reach US$ 955.12 million by 2031; it is expected to register a CAGR of 8.6% during 2023-2031.

Compression wraps for legs are designed to manage and alleviate the symptoms of lymphedema. These wraps help with the flow of lymph fluids and decrease swelling by applying controlled pressure to the affected areas of the leg. Compared to traditional compression stockings, compression wraps are adjustable, making them an ideal choice for individuals having difficulty putting on stockings or are experiencing fluctuating levels of edema. Adjustable compression wraps are considerably less expensive and more effective in achieving ulcer healing. Therefore, adjustable compression wraps are a powerful, self-applicable, and cost-effective alternative to inelastic bandages in treating venous leg ulcers. The increasing occurrence of venous conditions and the growing incidence of cancer leading to lymphedema are noteworthy factors contributing to the expansion of the Latin America chemiluminescence immunoassay market size. However, the availability of alternate treatments hinders the Latin America chemiluminescence immunoassay market growth as conditions such as lymphedema, chronic venous insufficiency, peripheral edema, venous stasis ulcers, and varicose veins can also be treated via medication and surgical procedures, especially minimally invasive procedures. Other treatment procedures used to treat the abovementioned conditions include foam sclerotherapy, laser treatment, ambulatory phlebectomy, and catheter-assisted procedures that use radiofrequency or laser energy. Techniques such as intermittent pneumatic compression devices are also used to prevent blood clots in the deep veins of the legs. It employs a device to mimic natural muscle contractions, aiding in venous return. Thus, the availability of alternative treatments, such as compression garments, devices, and therapies for the treatment of the abovementioned conditions, hampers the growth of the Latin America chemiluminescence immunoassay market.

Application-Based Insights

Based on application, the Latin America chemiluminescence immunoassay market is segmented into oncology, fertility, endocrinology, cardiology, infectious diseases, diabetes, and others. The oncology segment held the largest Latin America chemiluminescence immunoassay market share in 2023. According to the Lancet, ~1.5 million new cancer cases and ~700,000 cancer-related deaths are annually recorded in Latin America and the Caribbean (LAC) region as of 2023. According to the World Health Organization, in Brazil, cancer is ranked as the second leading cause of death, resulting in 227,920 deaths in 2018. It also reports that the age-adjusted death rate due to cancer is 111 per 100,000 for men and 95 per 100,000 for women. According to the Revista Brasileira de Cancerologia, nearly 704,000 new cancer cases were reported in Brazil in 2023. For instance, the EDI Human Chromogranin A CLIA Kit is indicated for the quantitative detection of human chromogranin A (CgA) levels in serum using the ECL100 or ECL25 immunoassay analyzer. This test may be used as an aid to detect patients with pheochromocytoma and neuroendocrine tumors (such as carcinoids, etc.).

In addition, the Fertility segment is expected to register the highest CAGR from 2023 to 2031. According to the National Institutes of Health (NIH), ~188 centers in 16 countries reported 87,732 females had their first menstrual cycles in 2020, and 12,778 childbirths and 14,405 live births were recorded in Latin America. According to the Comision Economica para America Latina y el Caribe, the total fertility rate (TFR) of Latin America, which fell below replacement level in 2015, was estimated at 1.85 live births per woman in 2022, with a further projection to drop to 1.68 by 2100. There has also been an increase in the average age of fertility. The Biopanda Prolactin chemiluminescence immunoassay test kit provides a means for the quantitative determination of prolactin in human serum. Chemiluminescent immunoassay has replaced radioimmunoassay in the measurement of serum progesterone as a current standard owing to factors such as high correlation and increased practicality. Thus, the factors mentioned above support Latin America chemiluminescence immunoassay market growth.

End User-Based Insights

Based on end user, the Latin America chemiluminescence immunoassay market is segmented into hospitals, blood banks, clinical laboratories, pharmaceutical & biotech companies, and others. The hospitals segment held the largest Latin America chemiluminescence immunoassay market share in 2023 and clinical laboratories segment is expected to register the highest CAGR in the market during 2023-2031. Immunodiagnostics tests are performed in different hospital departments, including clinical microbiology labs, pathological labs, serological labs, histopathology and hematology sections, clinical biochemistry labs, and hospital wards. Some A few immunodiagnostic instruments provide quick results, while samples are sent to specialized laboratories in the case of complex tests. The rising demand for point-of-care (POC) immunoassay testing products in hospital settings benefits the CLIA market. At present, CLIA tests are employed to detect tumor markers and diagnose infectious diseases, endocrine disorders, diabetes, and so on. With such varied applications in one automated system, CLIA systems find significant applicability in hospitals.

However, Diagnostic laboratories, built in adherence to domestic or international regulatory requirements, use CLIA-based kits and instruments for providing diagnostics services to hospitals, clinics, at-home care setups, etc. The surging prevalence of chronic and infectious diseases in Latin America, and the practice of outsourcing immunodiagnostics procedures are the factors supporting the Latin America chemiluminescence immunoassay market growth in the diagnostic laboratories segment.

The Global Cancer Observatory, OECD, and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the Latin America chemiluminescence immunoassay market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Research Methodology

  • 2.1 Coverage
  • 2.2 Secondary Research
  • 2.3 Primary Research

3. Latin America Chemiluminescence Immunoassay (CLIA) Market Landscape

  • 3.1 Market Overview
  • 3.2 PEST Analysis

4. Latin America Chemiluminescence Immunoassay (CLIA) Market - Key Market Dynamics

  • 4.1 Latin America Chemiluminescence Immunoassay Market - Key Market Dynamics
  • 4.2 Market Drivers:
    • 4.2.1 Rising Incidence of Infectious Diseases
    • 4.2.2 Growing Use of Point-of-Care Diagnostics
  • 4.3 Market Restraints
    • 4.3.1 Inadequate Reimbursement
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Focus on R&D
  • 4.5 Future Trends
    • 4.5.1 Technological Advancement
  • 4.1 Impact of Drivers and Restraints:

5. Latin America Chemiluminescence Immunoassay (CLIA) Market Analysis

  • 5.1 Chemiluminescence Immunoassay (CLIA) Market
    • 5.1.1 Overview
    • 5.1.2 Chemiluminescence Immunoassay (CLIA): Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)

6. Latin America Chemiluminescence Immunoassay (CLIA) Market Analysis - by Application

  • 6.1 Oncology
    • 6.1.1 Overview
    • 6.1.2 Oncology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Fertility
    • 6.2.1 Overview
    • 6.2.2 Fertility: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Endocrinology
    • 6.3.1 Overview
    • 6.3.2 Endocrinology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Cardiology
    • 6.4.1 Overview
    • 6.4.2 Cardiology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.5 Infectious Diseases
    • 6.5.1 Overview
    • 6.5.2 Infectious Diseases: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.6 Diabetes
    • 6.6.1 Overview
    • 6.6.2 Diabetes: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)

7. Latin America Chemiluminescence Immunoassay (CLIA) Market Analysis - by End User

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Hospitals: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Blood Banks
    • 7.2.1 Overview
    • 7.2.2 Blood Banks: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Clinical Laboratories
    • 7.3.1 Overview
    • 7.3.2 Clinical Laboratories: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Pharmaceutical & Biotech Companies
    • 7.4.1 Overview
    • 7.4.2 Pharmaceutical & Biotech Companies: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)

8. Latin America Chemiluminescence Immunoassay (CLIA) Market - Regional Analysis

  • 8.1 Overview
  • 8.2 Latin America
    • 8.2.1 Latin America Chemiluminescence Immunoassay (CLIA) Market Overview
    • 8.2.2 Latin America: Latin America Chemiluminescence Immunoassay (CLIA)- Revenue and Forecast to 2031 (US$ Million)
      • 8.2.2.1 Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast Analysis - by Application
      • 8.2.2.2 Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast Analysis - by End User
      • 8.2.2.3 Brazil: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.3.1 Brazil: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.3.2 Brazil: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.4 Argentina: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.4.1 Argentina: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.4.2 Argentina: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.5 Chile: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.5.1 Chile: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.5.2 Chile: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.6 Mexico: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.6.1 Mexico: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.6.2 Mexico: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User
      • 8.2.2.7 Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.2.2.7.1 Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by Application
        • 8.2.2.7.2 Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market Breakdown, by End User

9. Company Profiles

  • 9.1 Sysmex Corp
    • 9.1.1 Key Facts
    • 9.1.2 Business Description
    • 9.1.3 Products and Services
    • 9.1.4 Financial Overview
    • 9.1.5 SWOT Analysis
    • 9.1.6 Key Developments
  • 9.2 Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • 9.2.1 Key Facts
    • 9.2.2 Business Description
    • 9.2.3 Products and Services
    • 9.2.4 Financial Overview
    • 9.2.5 SWOT Analysis
    • 9.2.6 Key Developments
  • 9.3 Bio-Rad Laboratories Inc
    • 9.3.1 Key Facts
    • 9.3.2 Business Description
    • 9.3.3 Products and Services
    • 9.3.4 Financial Overview
    • 9.3.5 SWOT Analysis
    • 9.3.6 Key Developments
  • 9.4 Merck KGaA
    • 9.4.1 Key Facts
    • 9.4.2 Business Description
    • 9.4.3 Products and Services
    • 9.4.4 Financial Overview
    • 9.4.5 SWOT Analysis
    • 9.4.6 Key Developments
  • 9.5 Abbott Laboratories
    • 9.5.1 Key Facts
    • 9.5.2 Business Description
    • 9.5.3 Products and Services
    • 9.5.4 Financial Overview
    • 9.5.5 SWOT Analysis
    • 9.5.6 Key Developments
  • 9.6 Thermo Fisher Scientific Inc.
    • 9.6.1 Key Facts
    • 9.6.2 Business Description
    • 9.6.3 Products and Services
    • 9.6.4 Financial Overview
    • 9.6.5 SWOT Analysis
    • 9.6.6 Key Developments
  • 9.7 Hoffmann-La Roche Ltd
    • 9.7.1 Key Facts
    • 9.7.2 Business Description
    • 9.7.3 Products and Services
    • 9.7.4 Financial Overview
    • 9.7.5 SWOT Analysis
    • 9.7.6 Key Developments
  • 9.8 DiaSorin SpA
    • 9.8.1 Key Facts
    • 9.8.2 Business Description
    • 9.8.3 Products and Services
    • 9.8.4 Financial Overview
    • 9.8.5 SWOT Analysis
    • 9.8.6 Key Developments
  • 9.9 Siemens Healthineers AG
    • 9.9.1 Key Facts
    • 9.9.2 Business Description
    • 9.9.3 Products and Services
    • 9.9.4 Financial Overview
    • 9.9.5 SWOT Analysis
    • 9.9.6 Key Developments
  • 9.10 Getein Biotech Inc.
    • 9.10.1 Key Facts
    • 9.10.2 Business Description
    • 9.10.3 Products and Services
    • 9.10.4 Financial Overview
    • 9.10.5 SWOT Analysis
    • 9.10.6 Key Developments

10. Appendix

  • 10.1 About The Insight Partners
  • 10.2 Glossary of Terms

List Of Tables

  • Table 1. Latin America Chemiluminescence Immunoassay (CLIA) Market Segmentation
  • Table 2. Latin America Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 3. Latin America Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 4. Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 5. Latin America: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 6. Brazil: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 7. Brazil: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 8. Argentina: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 9. Argentina: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 10. Chile: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 11. Chile: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 12. Mexico: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 13. Mexico: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 14. Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market- Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 15. Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 16. Glossary of Terms, Latin America Chemiluminescence Immunoassay (CLIA) Market

List Of Figures

  • Figure 1. Analysis
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Chemiluminescence Immunoassay (CLIA): Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 4. Latin America Chemiluminescence Immunoassay (CLIA) Market Share (%) - by Application (2024 and 2031)
  • Figure 5. Oncology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 6. Fertility: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Endocrinology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cardiology: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Infectious Diseases: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Diabetes: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Latin America Chemiluminescence Immunoassay (CLIA) Market Share (%) - by End User (2024 and 2031)
  • Figure 13. Hospitals: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Blood Banks: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Clinical Laboratories: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Pharmaceutical & Biotech Companies: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Others: Latin America Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Latin America Chemiluminescence Immunoassay (CLIA) Market Breakdown by Countries, 2023 and 2031 (%)
  • Figure 19. Latin America: Latin America Chemiluminescence Immunoassay (CLIA), by Key Country - Revenue (2023) (USD Million)
  • Figure 20. Latin America: Latin America Chemiluminescence Immunoassay (CLIA)- Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Brazil: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Argentina: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Chile: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Mexico: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. Rest of Latin America: Chemiluminescence Immunoassay (CLIA) Market - Revenue and Forecast to 2031(US$ Million)